Change to "SK3 Group, Inc. d.b.a. Medical Greens"
Post# of 36729
Posted On: 03/12/2014 12:26:48 PM
Change to "SK3 Group, Inc. d.b.a. Medical Greens" noted in today's PR.
Mar 12, 2014
SK3 Group Completes Beta Testing of Broad Use T-Hydrocan(TM) and Prepares for Distribution to Collectives and Pharmajanes.com
LOS ANGELES, CA--(Marketwired - Mar 12, 2014) - SK3 Group, Inc. (OTC Pink: SKTO) (PINKSHEETS: SKTO), doing business as Medical Greens, through its subsidiary Berkely Bio-Organic Research Laboratories, has completed beta-testing of the initial offering in its recently announced phyto-cannabinoid product line, T-Hydrocan™. T-Hydrocan™ RMC 40 contains 40 mg. of refined mixed cannabinoids which have been extracted from cannabis flowers utilizing solvents approved for food contact, refined via numerous filtration and separation processes to remove as many of the non-cannabinoid elements as possible, and pressed into a chewable tablet.
Investor Relations
SK3 Group, Inc. d.b.a Medical Greens
investors@medicalgreens.com
Compare to previous PRs issued by SK3 Group:
Mar 11, 2014
SK3 Group's Berkeley Bio Organic Research Laboratories Has Developed Cutting Edge Nutritional Supplement, Alzatrex(TM), Targeted to Assist Those With Memory Deficits and to Reduce Brain Fog From MMJ Use
LOS ANGELES, CA--(Marketwired - Mar 11, 2014) - SK3 Group's (OTC Pink: SKTO) (PINKSHEETS: SKTO) Berkeley Bio Organic Research Laboratories has developed "Alzatrex"™, an herbal supplement that may be taken orally that combines medical cannabis with a proprietary formula of herbal COX-2 inhibitors. Research has shown that delta9-THC, the main active ingredient in medical marijuana, decreases beta-amyloid plaques and neurodegeneration in Alzheimer's disease, and that it is reduced further by the addition of a COX-2 inhibitor. A COX-2 inhibitor is a form of NSAID that is used to reduce pain.
SK3 Group
Investor Relations
investors@medicalgreens.com
Feb 14, 2014
SK3 Group's (OTC PINK: SKTO) Medical Greens Is Pleased to Announce That the First Bottles of Dharmanol(TM) Are Shipping and Will Be Immediately Available on www.pharmajanes.com Among Other Places
LOS ANGELES, CA--(Marketwired - Feb 14, 2014) - SK3 Group, Inc's (OTC Pink: SKTO) subsidiary Medical Greens is pleased to announce that the first bottles of Dharmanol™ Whole Plant tablets, for which Medical Greens has the exclusive license, are shipping today. Dharmanol™ is a medical cannabis-based supplement that contains all of the natural elements of the cannabis/hemp plant that are thought to promote healing, with the exception of THC, the molecule which is responsible for the psychoactive effect -- or "high" -- of marijuana.
Medical Greens
investors@medicalgreens.com
Investor Relations
Jan 31, 2014
Medical Greens Announces Launch of Janes Card Loyalty and Payment Card
LOS ANGELES, CA--(Marketwired - Jan 31, 2014) - SK3 Group, Inc's (OTC Pink: SKTO) subsidiary Medical Greens ("the Company") is pleased to announce that it has officially launched its Janes Card™ (www.janescard.com) benefits and payment card. The Janes Card™ is a universal benefits-based prepaid card along with a payment solution and rewards program that is intended to build customer loyalty for all retailers that accept it throughout California.
Investor Relations
investors@medicalgreens.com
Jan 29, 2014
Medical Greens to Become Exclusive Distributor of Monarch Vaporizer Pens via PharmaJanes.com and Through Its Affiliated Dispensaries
LOS ANGELES, CA--(Marketwired - Jan 29, 2014) - SK3 Group, Inc.'s (OTC Pink: SKTO) subsidiary Medical Greens ("the Company") is pleased to announce that it has signed an exclusive distribution agreement for the Monarch Vaporizer from Monarch Vapes, a provider of portable personal vaporizers.
Jan 24, 2014
SK3 Group's (OTC Pink: SKTO) Medical Greens Signs Management Agreement With Medical Marijuana Logistics Company to Provide Door-to-Door Product Delivery Safely and on Time
LOS ANGELES, CA--(Marketwired - Jan 24, 2014) - SK3 Group, Inc's (OTC Pink: SKTO) subsidiary Medical Greens ("the Company") is pleased to announce that it has signed a new management agreement with a medical marijuana-focused logistics company that will be providing secure, timely, and customer-focused door-to-door delivery of medical marijuana products to dispensaries across the entire state of California.
SK3 Group, Inc.
Investor Relations
investors@medicalgreens.com
Jan 13, 2014
Medical Greens (SKTO) Announces New Topical Medical Cannabis Product Line Topikoil(TM)
LOS ANGELES, CA--(Marketwired - Jan 13, 2014) - SK3 Group, Inc.'s (OTC Pink: SKTO) subsidiary Medical Greens ("the Company") is pleased to announce that Berkeley Bio-Organic Research Laboratories is seeking participants to test their new proprietary cannabinoid-based skin care products -- Dharmanol™ Topikoil™, and T-Hydrocan™ Topikoil™.
SK3 Group, Inc.
investors@medicalgreens.com
Investor Relations
=====================================================================
AEGY PR
Feb 20, 2014
PharmaJanes(TM) (OTCBB: AEGY), in Affiliation With Medical Greens (OTC Pink: SKTO) Announces Expanded Delivery Service Area
LOS ANGELES, CA--(Marketwired - Feb 20, 2014) - Alternative Energy Partners (OTCBB: AEGY) (OTCQB: AEGY), doing business as PharmaJanes™ ("the Company"), working in conjunction with its partner, SK3 Group (OTC Pink: SKTO), is pleased to announce that its e-commerce order servicing platform (www.PharmaJanes.com), has expanded its delivery service area to include additional zip code areas in California.
Mar 12, 2014
SK3 Group Completes Beta Testing of Broad Use T-Hydrocan(TM) and Prepares for Distribution to Collectives and Pharmajanes.com
LOS ANGELES, CA--(Marketwired - Mar 12, 2014) - SK3 Group, Inc. (OTC Pink: SKTO) (PINKSHEETS: SKTO), doing business as Medical Greens, through its subsidiary Berkely Bio-Organic Research Laboratories, has completed beta-testing of the initial offering in its recently announced phyto-cannabinoid product line, T-Hydrocan™. T-Hydrocan™ RMC 40 contains 40 mg. of refined mixed cannabinoids which have been extracted from cannabis flowers utilizing solvents approved for food contact, refined via numerous filtration and separation processes to remove as many of the non-cannabinoid elements as possible, and pressed into a chewable tablet.
Investor Relations
SK3 Group, Inc. d.b.a Medical Greens
investors@medicalgreens.com
Compare to previous PRs issued by SK3 Group:
Mar 11, 2014
SK3 Group's Berkeley Bio Organic Research Laboratories Has Developed Cutting Edge Nutritional Supplement, Alzatrex(TM), Targeted to Assist Those With Memory Deficits and to Reduce Brain Fog From MMJ Use
LOS ANGELES, CA--(Marketwired - Mar 11, 2014) - SK3 Group's (OTC Pink: SKTO) (PINKSHEETS: SKTO) Berkeley Bio Organic Research Laboratories has developed "Alzatrex"™, an herbal supplement that may be taken orally that combines medical cannabis with a proprietary formula of herbal COX-2 inhibitors. Research has shown that delta9-THC, the main active ingredient in medical marijuana, decreases beta-amyloid plaques and neurodegeneration in Alzheimer's disease, and that it is reduced further by the addition of a COX-2 inhibitor. A COX-2 inhibitor is a form of NSAID that is used to reduce pain.
SK3 Group
Investor Relations
investors@medicalgreens.com
Feb 14, 2014
SK3 Group's (OTC PINK: SKTO) Medical Greens Is Pleased to Announce That the First Bottles of Dharmanol(TM) Are Shipping and Will Be Immediately Available on www.pharmajanes.com Among Other Places
LOS ANGELES, CA--(Marketwired - Feb 14, 2014) - SK3 Group, Inc's (OTC Pink: SKTO) subsidiary Medical Greens is pleased to announce that the first bottles of Dharmanol™ Whole Plant tablets, for which Medical Greens has the exclusive license, are shipping today. Dharmanol™ is a medical cannabis-based supplement that contains all of the natural elements of the cannabis/hemp plant that are thought to promote healing, with the exception of THC, the molecule which is responsible for the psychoactive effect -- or "high" -- of marijuana.
Medical Greens
investors@medicalgreens.com
Investor Relations
Jan 31, 2014
Medical Greens Announces Launch of Janes Card Loyalty and Payment Card
LOS ANGELES, CA--(Marketwired - Jan 31, 2014) - SK3 Group, Inc's (OTC Pink: SKTO) subsidiary Medical Greens ("the Company") is pleased to announce that it has officially launched its Janes Card™ (www.janescard.com) benefits and payment card. The Janes Card™ is a universal benefits-based prepaid card along with a payment solution and rewards program that is intended to build customer loyalty for all retailers that accept it throughout California.
Investor Relations
investors@medicalgreens.com
Jan 29, 2014
Medical Greens to Become Exclusive Distributor of Monarch Vaporizer Pens via PharmaJanes.com and Through Its Affiliated Dispensaries
LOS ANGELES, CA--(Marketwired - Jan 29, 2014) - SK3 Group, Inc.'s (OTC Pink: SKTO) subsidiary Medical Greens ("the Company") is pleased to announce that it has signed an exclusive distribution agreement for the Monarch Vaporizer from Monarch Vapes, a provider of portable personal vaporizers.
Jan 24, 2014
SK3 Group's (OTC Pink: SKTO) Medical Greens Signs Management Agreement With Medical Marijuana Logistics Company to Provide Door-to-Door Product Delivery Safely and on Time
LOS ANGELES, CA--(Marketwired - Jan 24, 2014) - SK3 Group, Inc's (OTC Pink: SKTO) subsidiary Medical Greens ("the Company") is pleased to announce that it has signed a new management agreement with a medical marijuana-focused logistics company that will be providing secure, timely, and customer-focused door-to-door delivery of medical marijuana products to dispensaries across the entire state of California.
SK3 Group, Inc.
Investor Relations
investors@medicalgreens.com
Jan 13, 2014
Medical Greens (SKTO) Announces New Topical Medical Cannabis Product Line Topikoil(TM)
LOS ANGELES, CA--(Marketwired - Jan 13, 2014) - SK3 Group, Inc.'s (OTC Pink: SKTO) subsidiary Medical Greens ("the Company") is pleased to announce that Berkeley Bio-Organic Research Laboratories is seeking participants to test their new proprietary cannabinoid-based skin care products -- Dharmanol™ Topikoil™, and T-Hydrocan™ Topikoil™.
SK3 Group, Inc.
investors@medicalgreens.com
Investor Relations
=====================================================================
AEGY PR
Feb 20, 2014
PharmaJanes(TM) (OTCBB: AEGY), in Affiliation With Medical Greens (OTC Pink: SKTO) Announces Expanded Delivery Service Area
LOS ANGELES, CA--(Marketwired - Feb 20, 2014) - Alternative Energy Partners (OTCBB: AEGY) (OTCQB: AEGY), doing business as PharmaJanes™ ("the Company"), working in conjunction with its partner, SK3 Group (OTC Pink: SKTO), is pleased to announce that its e-commerce order servicing platform (www.PharmaJanes.com), has expanded its delivery service area to include additional zip code areas in California.
(0)
(0)